Hipril Tablets contain Lisinopril 5 mg.

Hipril Tablets contain Lisinopril, a long-acting angiotensin-converting enzyme (ACE) inhibitor that effectively lowers blood pressure by inhibiting the formation of angiotensin II. This results in reduced vasoconstriction, decreased aldosterone secretion, and improved cardiovascular function. Hipril provides once-daily blood pressure control and is indicated for the management of essential hypertension and congestive heart failure, helping reduce cardiac workload and improve hemodynamic stability.

Hipril Tablets are indicated for the treatment of essential hypertension and congestive heart failure (CHF).

Lisinopril is a peptidyl dipeptidase inhibitor that inhibits the angiotensin-converting enzyme (ACE), preventing the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. Reduced angiotensin II levels decrease vasoconstriction and aldosterone secretion, resulting in vasodilation, reduced sodium and water retention, lowered blood pressure, and reduced cardiac workload.

The recommended dosage is one tablet orally once daily, or as directed by the physician.

Hipril Tablets are contraindicated in patients with known hypersensitivity to Lisinopril or any component of the formulation.